Icecure Medical is trading 6.03% up at $2.99 after closing at $2.82 on August 17, 2026, with no clear company-specific announcement explaining the after-hours rebound.
- Its latest notable filing, dated August 17, was a beneficial-ownership statement; the widely surfaced $5.5 million private placement was announced June 17.
- First-half revenue strengthened, but the net loss widened, which may concern investors. Available evidence does not establish earnings, macro conditions, or a late-breaking event as the cause.